<PAGE>
 
                                                                      EXHIBIT 99

                                 RISK FACTORS

THERE IS NO ASSURANCE THAT THE PROPOSED BUSINESS OF ORBIT DESCRIBED HEREIN WILL
BE COMMERCIALLY VIABLE.  IN ADDITION, ACTUAL RESULTS OF THE DEVELOPMENT
ACTIVITIES, TECHNOLOGICAL DEVELOPMENTS, MARKET AND COMPETITIVE CONDITIONS,
RESULTS OF OPERATIONS AND OTHER FACTORS MAY REQUIRE SIGNIFICANT MODIFICATIONS OF
ALL OR PART OF THE PROPOSED BUSINESS.

    Potential Securities Act Liabilities.  Current management believes the
Company has sold securities and notes without registration under the Securities
Act of 1933, as amended (the "Act"), or without qualification under the
securities (blue sky) laws of certain states. As a result of such sales, and a
subsequent transfer of the shares by the original purchasers, the Company may
not be able to claim valid exemptions for such sales since the burden of proving
any exemption is on the Company. Therefore, no assurances can be given as to any
liability which may result from violations of the registration or qualifications
provisions of the federal or state securities laws. The Company may thus may
have a continuing contingent liability under the Act, the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and various state securities laws
for an undetermined amount for an undetermined period.

    Potential Corporation Law Liability.  The Company is conducting an internal
audit, which has revealed that substantial shares of the Common Stock issued to
former directors, and officers may be subject to cancellation. This would reduce
the number of outstanding shares significantly. Between December 16, 1992 and
February 17, 1994, the Company may have issued more shares of Common Stock than
it had authorized under its Certificate of Incorporation.

    Potential Liability for Rescission of Dividends.  In February 1994, the
Company declared a stock dividend on a ten to one basis of the following
corporations, all of which were contemplated subsidiaries of the Company: the
TiTRODE Corporation, the Metafuse Corporation, Electronics Recovery Systems,
Inc., the Titherm Technology Corporation and Shield Safe, Inc. In connection
with such dividends, each subsidiary was to receive a license for a particular
technology owned by the Company. The Company's Board of Directors has
subsequently rescinded such stock dividends principally because of the concern
that such dividends may not comply with the Delaware General Corporations Law
since such dividends would strip the Company of most of its valuable assets. It
is possible that a shareholder could challenge the rescission of the dividend
and it is unclear whether a Delaware court will uphold such rescission. Thus,
the shareholders entitled to such dividends may have a right to seek payment of
such dividend.

    Start-Up Company.  To date the Company has been engaged in the development
of technologies and intends to commercially exploit certain of its technologies
with third parties. Until the commencement of sales or licensing of the
technologies, the Company will have no operating revenues but will continue to
incur substantial expenses. No assurances can be given that the Company can
complete development of any technologies or that if a technology is, or in the
future may be, fully developed, that it can be manufactured by others on a large
scale basis or at a feasible cost. Further, no assurance can be given that any
technology will receive market acceptance. The Company is subject to all the
risks inherent in the establishment of a new enterprise and the marketing and
manufacturing of new products, many of which risks are beyond the control of the
Company. There can be no assurances that the proposed business of the Company
<PAGE>
 
described herein will be commercially viable. In addition, actual results of the
development activities, technological developments, market and competitive
conditions, results of operation and other factors may require significant
modification of all or part of the Company's proposed business plan. See Item 6.
Management's Plan of Operation.

    Accumulated Deficit; Operating Losses; Going Concern.  For the year ended
December 31, 1997, the Company incurred an aggregate operating loss of $877,054.
At December 31, 1997, the Company had an accumulated deficit of $14,895,616
                                                                -----------
and a working capital deficit of $3,477,041. The Company has a ratio of
liabilities to tangible assets of 28.2 to 1 as of December 31, 1997. Such
operating losses, accumulated deficit and the working capital deficit have
increased since such date. The losses are principally due to (1) the Company's
unsuccessful search for license, joint venture, or partnership arrangements with
entities in industries aligned with the Company's technologies, and (2) a lack
of technological and business focus. The report of the Company's independent
certified public accountants is qualified with regard to the ability of the
Company to continue as a going concern.

    Risks of Foreign Operations.  Certain studies and tests of the technologies
are being conducted outside of the United States.  Certain customers for these
technologies may be outside the United States, in various parts of the world,
including Russia and Ukraine.  Thus, the Company may be subject to the risks of
operations including currency fluctuations, import/export controls, lack of a
well-defined business or legal system, arbitrary government actions, and
instability of a political system.

    Lack of Patent Protection.  Patents do not cover most of the Company's
technologies. Of the technologies described herein, the Company's patents cover
only the electronic recovery system, the original Metafusion Process, and a
patent pending for the Polymer Encapsulation System (PET).  Those patents held
by the Company may be infringed upon by others and there can be no assurance
that the Company will be able to afford the high cost of filing and pursuing an
infringement action against any such alleged infringing party.  In addition,
there can be no assurance that any particular aspect of the Company's
technologies will not be found to infringe the claims of other existing patents.
Certain technology embodied in the patents covering the Company's Metafusion
Process may incorporate technology embodied in patents owned by other entities.
Even if other patents infringed, Orbit may not have the financial resources to
prosecute. The Company has also filed a number of patent applications. There can
be no assurance that additional patents will be issued in respect of the patent
applications pending. The Company also relies, to a lesser extent, on trade
secrets and confidential disclosure agreements to protect its technology.
Neither the issuance of patents nor the use of trade secrets will necessarily
protect the Company from other persons using technologies similar to those
covered by the Company's patents or trade secrets.

    Lack of Full Time Research and Development Team.  In addition to the
Company's officers, Orbit currently uses third party subcontractors and non-
affiliated laboratories to develop and review applications of its technologies.

    Dependence on Key Individuals.  The success of the Company is dependent upon
among other things, the services of Dr. Stephen V. Prewett and Dr. Christopher
M. Miller, both consultants and advisors with the company.  The loss of the
services of Dr. Prewett and/or Dr. Miller for any reason could have a material
adverse effect of the prospects of the Company.
<PAGE>
 
    Transactions with Prior Management.  During the period prior to January 1996
there had been substantial transactions between the Company and members of
management, including Adrian Joseph, Tatum C. Singletary and Richard A. Wall.
These transactions include the alleged exchange of technology developed or
purchased by Mr. Joseph for shares of Common Stock and/or the payment of shares
for debt or for services rendered to others. No assurances can be given that the
value of the technology transferred or the services rendered or other items of
value exchanged equal the value of the Common Stock transferred to such parties.
Such transfers were not approved by an independent majority of the board of
directors and thus may not have been on the same terms as if they were
transactions with unaffiliated third parties. An audit is being conducted to
review these transactions. Management is currently attempting to rectify the
apparent misconduct in these transactions. (See item 3. Legal Proceedings.)

    Year 2000 Issues.  The Year 2000 issue is the result of computer programs
using two digits rather than four to define the applicable year.  Such software
may recognize a date using "00" as the year 1900 rather than the year 2000. This
could result in system failures or miscalculations leading to disruptions in the
Company's activities and operations (the "Year 2000" or "Y2K" issue).

The Company's information systems currently are made up of networked computers
which are used internally and are not linked to any outside sources other than
the browser used by the Company.  The Company's future information system will
cover a spectrum of software applications for its operations, certain of these
may be custom designed.

The Company has initiated formal communication with all of its significant
suppliers to determine the extent to which the Company is vulnerable to the
failure of such suppliers to resolve their own Year 2000 problems.

After an analysis of the Company's exposure to the impact of "year 2000 issues"
(i.e. issues that may arise resulting from computer programs that use only the
last two, rather than all four, digits of the year), the Company believes that
such commercial software is already substantially year 2000 compliant, and that
completion of year 2000 compliance should not have a material impact on the
Company's business, operations or financial condition.